Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?

Abstract

MAFLD and NAFLD have similar clinical profiles and long-term outcomes. The increased liver-related mortality among NAFLD is driven by insulin resistance, and among MAFLD is primarily driven by ALD.